Shares of Moderna rose 4.64% to $149.64 at 11:12 EST on Thursday, following yesterday’s upward trend. The Nasdaq Stock Market is rising 0.66% to $12,430.90, following yesterday’s downward trend, on what up to now seems, a somewhat positive trend trading session today.
Moderna’s last close was $143.00, 19.29% under its 52-week high of $178.50.
Moderna’s sales growth is 1425.2% for the current quarter and 12348.6% for the next. The company’s growth estimates for the current quarter is a negative 48.6% and positive 528.6% for the next.
Year-on-year quarterly revenue growth grew by 826.4%, now sitting on 246.7M for the twelve trailing months.
Moderna’s Stock Top and Bottom Yearly Value
Moderna’s stock is valued at $149.64 at 11:12 EST, way below its 52-week high of $178.50 and way higher than its 52-week low of $17.68.
Moderna’s Moving Average
Moderna’s value is way higher than its 50-day moving average of $86.56 and way above its 200-day moving average of $72.67.
Previous days news about Moderna
Moderna falls after Merck sells stake in the vaccine maker. According to yesterday’s article on Bloomberg Quint, “Moderna Inc. fell in premarket trading in New York after Merck & Co. said it sold its stake in the biotechnology company that’ss in the midst of developing a Covid-19 vaccine.”
Astra data, Novavax delay spur Moderna vaccine demand, CEO says. According to yesterday’s article on Bloomberg Quint, “Confusion about AstraZeneca Plc’s Covid-19 vaccine data and delays in Novavax Inc’s clinical trials are boosting demand worldwide for Moderna Inc.’s shot”